Scientists identify DNA signature linked to prostate cancer severity

Findings published in renowned journal Nature



January 9, 2017 – TORONTO, ON – The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature. Led by Drs. Robert Bristow of the Princess Margaret Cancer Centre and Paul Boutros of the Ontario Institute for Cancer Research, CPC-GENE has uncovered the full set of mutations that can occur in the most common cancer in men. By fully cataloging these mutations, the CPC-GENE team was able to create a new signature that predicts at an early stage whether a prostate cancer tumour will become aggressive or not, allowing for personalized treatment. 


“We hope that this research mode of testing will now go into the clinical mode in the next two to five years, and really change clinical practice for men with prostate cancer in Canada and worldwide,” said Dr. Bristow.

“This work really gives us a map to what is going on inside a prostate cancer cell, and will become the scaffold on which precision therapy will be built,” said Dr. Boutros.

“I applaud the researchers and everyone involved in making this possible,” said Reza Moridi, Ontario Minister of Research, Innovation and Science. “Collaborations like this are key to driving scientific discoveries and ultimately delivering better care for prostate cancer patients.”

Through funding of approximately $20 million, research of this magnitude has been made possible through a partnership between the Movember Foundation, Prostate Cancer Canada, and the Ontario Institute for Cancer Research, who have released the following joint statement:

“From the tireless work of researchers to the selfless giving of donors, we applaud the efforts of everyone who has played a role in helping make CPC-GENE possible. Since its beginnings as an ambitious undertaking that was massive in scope, the goal of this project has been to greatly improve personalized care for men with prostate cancer. The findings published in Nature represent a monumental stride towards that goal. Together, we will continue to advance this important work on behalf of the one in eight Canadian men who will be diagnosed with prostate cancer and their families.”

Full Article: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature20788.html
-30-

For more information please contact:
Adam Miller
Manager, Communications
Prostate Cancer Canada
416 441 2131 ext. 235
adam.miller@prostatecancer.ca



Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Taking fundraising to new heights: Canadians climb 5,000 feet for prostate cancer research

Toronto, ON - March 9, 2017 - Over the course of the last few weeks, corporate teams located in Vancouver, Calgary and Toronto raised more than $650,000 for prostate cancer research by competing in Prostate Cancer Canada’s (PCC) 4th annual Step Up Challenge, presented by Scotiabank.
More

Prostate Cancer Canada's Rock the Road Raffle sells out for 5th consecutive year

March 1, 2017 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and have a chance to win a one-of-a-kind dream car.
More

Prostate Cancer Canada Partners with Screw Cancer™

TORONTO, ON - Starting today, you can screw cancer and give hope in your local community by purchasing the Screw Cancer™ screwdriver in support of Prostate Cancer Canada.
More


Click here for news archive